Lonza has expanded mammalian production capacity at its Slough, UK facility. Based on the increased demand for biopharmaceutical development and clinical manufacturing services, two 1000L single-use bioreactors will be installed at the site. According to the company, this expansion will significantly increase the existing single-use manufacturing capacity in Slough while allowing current operations to continue without interruption. Lonza’s cGMP facility in Slough is its center of excellence f...